Serial 86744217
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 02 Apr 2023)
What this means for you
Registered since 11 Oct 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86744217
- Registration number
- 5060787
- Mark type
- Design / logo
- Filed
- 01 Sept 2015
- Published for opposition
- 15 Dec 2015
- Registered
- 11 Oct 2016
- Attorney of record
- Cheryl A. Withycombe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- AbbVie Inc, North Chicago, IL, US
- AbbVie Inc, North Chicago, IL, US
- AbbVie Inc, North Chicago, IL, US
Prosecution history
- 11 Oct 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 Apr 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Apr 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 02 Apr 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Sept 2022 — TEAS SECTION 8 & 15 RECEIVED
- 11 Oct 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Oct 2016 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Sept 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Sept 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Aug 2016 — USE AMENDMENT FILED
- 01 Sept 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Aug 2016 — TEAS STATEMENT OF USE RECEIVED
- 09 Feb 2016 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Dec 2015 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED